Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Gerstein

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Schizophrenia Research|September 4, 2007
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) studyL P Voruganti, Z Punthakee, R J Van Lieshout, et al.
Diabetologia|April 8, 2010
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetesL de Koning, H C Gerstein, J Bosch, et al.
Translational Psychiatry|August 12, 2015
Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic populationZ Samaan, S Garasia, H C Gerstein, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 3, 1998
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes AssociationS Meltzer, L Leiter, D Daneman, et al.
Clinical Nephrology|March 25, 2005
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE studyJ F E Mann, Q L Yi, P Sleight, et al.
Diabetes, Obesity & Metabolism|August 22, 2006
Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trialB Zinman, S B Harris, H C Gerstein, et al.
Circulation|August 30, 2000
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) RegistryK Malmberg, S Yusuf, H C Gerstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 12, 2012
Increased cardiovascular risk after pre-eclampsia in women with dysglycaemiaS D McDonald, S Yusuf, M W Walsh, et al.
Diabetes Care|June 22, 2000
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study InvestigatorsH C Gerstein, J F Mann, J Pogue, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 4, 2014
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trialZ Punthakee, N Alméras, J-P Després, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Schizophrenia Research|September 4, 2007
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) studyL P Voruganti, Z Punthakee, R J Van Lieshout, et al.
Diabetologia|April 8, 2010
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetesL de Koning, H C Gerstein, J Bosch, et al.
Translational Psychiatry|August 12, 2015
Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic populationZ Samaan, S Garasia, H C Gerstein, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 3, 1998
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes AssociationS Meltzer, L Leiter, D Daneman, et al.
Clinical Nephrology|March 25, 2005
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE studyJ F E Mann, Q L Yi, P Sleight, et al.
Diabetes, Obesity & Metabolism|August 22, 2006
Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trialB Zinman, S B Harris, H C Gerstein, et al.
Circulation|August 30, 2000
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) RegistryK Malmberg, S Yusuf, H C Gerstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 12, 2012
Increased cardiovascular risk after pre-eclampsia in women with dysglycaemiaS D McDonald, S Yusuf, M W Walsh, et al.
Diabetes Care|June 22, 2000
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study InvestigatorsH C Gerstein, J F Mann, J Pogue, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 4, 2014
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trialZ Punthakee, N Alméras, J-P Després, et al.
Pageof 9